Savoldo B - Search Results

1

ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells.

Bergaggio E, Tai WT, Aroldi A, Mecca C, Landoni E, Nüesch M, Mota I, Metovic J, Molinaro L, Ma L, Alvarado D, Ambrogio C, Voena C, Blasco RB, Li T, Klein D, Irvine DJ, Papotti M, Savoldo B, Dotti G, Chiarle R. Bergaggio E, et al. Among authors: savoldo b. Cancer Cell. 2023 Dec 11;41(12):2100-2116.e10. doi: 10.1016/j.ccell.2023.11.004. Epub 2023 Nov 30. Cancer Cell. 2023. PMID: 38039964

2

Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.

Savoldo B, Cubbage ML, Durett AG, Goss J, Huls MH, Liu Z, Teresita L, Gee AP, Ling PD, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. J Immunol. 2002 Jan 15;168(2):909-18. doi: 10.4049/jimmunol.168.2.909. J Immunol. 2002. PMID: 11777989

3

Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease.

Bollard CM, Savoldo B, Rooney CM, Heslop HE. Bollard CM, et al. Among authors: savoldo b. Acta Haematol. 2003;110(2-3):139-48. doi: 10.1159/000072463. Acta Haematol. 2003. PMID: 14583674 Review.

4

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients.

Lee TC, Savoldo B, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Barshes NR, Scott JD, Bristow LJ, O'Mahony CA, Goss JA. Lee TC, et al. Among authors: savoldo b. Am J Transplant. 2005 Sep;5(9):2222-8. doi: 10.1111/j.1600-6143.2005.01002.x. Am J Transplant. 2005. PMID: 16095501 Free article.

5

Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.

Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA. Lee TC, et al. Among authors: savoldo b. Clin Transplant. 2006 May-Jun;20(3):389-93. doi: 10.1111/j.1399-0012.2006.00498.x. Clin Transplant. 2006. PMID: 16824159

6

Immunotherapy for post-transplant lymphoproliferative disease.

Straathof KC, Savoldo B, Heslop HE, Rooney CM. Straathof KC, et al. Among authors: savoldo b. Br J Haematol. 2002 Sep;118(3):728-40. doi: 10.1046/j.1365-2141.2002.03594.x. Br J Haematol. 2002. PMID: 12181039 Free article. Review. No abstract available.

7

Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.

Lee TC, Goss JA, Rooney CM, Heslop HE, Barshes NR, Caldwell YM, Gee AP, Scott JD, Savoldo B. Lee TC, et al. Among authors: savoldo b. Clin Transplant. 2006 Nov-Dec;20(6):689-94. doi: 10.1111/j.1399-0012.2006.00537.x. Clin Transplant. 2006. PMID: 17100717

8

Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease.

Heslop HE, Savoldo B, Rooney CM. Heslop HE, et al. Among authors: savoldo b. Best Pract Res Clin Haematol. 2004 Sep;17(3):401-13. doi: 10.1016/j.beha.2004.05.007. Best Pract Res Clin Haematol. 2004. PMID: 15498712 Review.

9

The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients.

Savoldo B, Heslop HE, Rooney CM. Savoldo B, et al. Leuk Lymphoma. 2000 Nov;39(5-6):455-64. doi: 10.3109/10428190009113376. Leuk Lymphoma. 2000. PMID: 11342329 Review.

10

Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications.

Leen AM, Sili U, Savoldo B, Jewell AM, Piedra PA, Brenner MK, Rooney CM. Leen AM, et al. Among authors: savoldo b. Blood. 2004 Feb 1;103(3):1011-9. doi: 10.1182/blood-2003-07-2449. Epub 2003 Oct 2. Blood. 2004. PMID: 14525768 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page